ERP27

gene
On this page

Also known as FLJ32115PDIA8

Summary

ERP27 (endoplasmic reticulum protein 27, HGNC:26495) is a protein-coding gene on chromosome 12p12.3, encoding Endoplasmic reticulum resident protein 27 (Q96DN0). Specifically binds unfolded proteins and may recruit protein disulfide isomerase PDIA3 to unfolded substrates.

This gene encodes a noncatalytic member of the protein disulfide isomerase (PDI) family of endoplasmic reticulum (ER) proteins. The canonical protein has an N-terminal signal sequence, two thioredoxin (TRX)-like domains and a C-terminal ER-retention sequence. Alternative splicing results in multiple transcript variants encoding distinct isoforms; some of which lack domains present in the canonical protein.

Source: NCBI Gene 121506 — RefSeq curated summary.

At a glance

  • GWAS associations: 5
  • Clinical variants (ClinVar): 49 total
  • MANE Select transcript: NM_152321

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26495
Approved symbolERP27
Nameendoplasmic reticulum protein 27
Location12p12.3
Locus typegene with protein product
StatusApproved
AliasesFLJ32115, PDIA8
Ensembl geneENSG00000139055
Ensembl biotypeprotein_coding
OMIM610642
Entrez121506

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000266397, ENST00000540097, ENST00000544881

RefSeq mRNA: 2 — MANE Select: NM_152321 NM_001300784, NM_152321

CCDS: CCDS73450, CCDS8670

Canonical transcript exons

ENST00000266397 — 7 exons

ExonStartEnd
ENSE000009362991493841514938537
ENSE000009363001493795214938052
ENSE000009363011493485614934993
ENSE000009363021492093214921048
ENSE000009363091491717814917303
ENSE000009363101491548914915686
ENSE000011001331491403914914782

Expression profiles

Bgee: expression breadth ubiquitous, 180 present calls, max score 99.40.

FANTOM5 (CAGE): breadth broad, TPM avg 1.9011 / max 1394.0271, expressed in 251 samples.

FANTOM5 promoters (10 alternative TSS)

Promoter IDTPM avgSamples expressed
1298901.120441
1298800.5626193
1298760.062024
1298790.043716
1298720.03568
1298780.02849
1298730.02018
1298770.01205
1298740.01166
1298750.00471

Top tissues by expression

247 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
body of pancreasUBERON:000115099.40gold quality
kidney epitheliumUBERON:000481997.23gold quality
epithelial cell of pancreasCL:000008395.11gold quality
right uterine tubeUBERON:000130293.48gold quality
pancreasUBERON:000126493.17gold quality
oviduct epitheliumUBERON:000480492.55gold quality
adult mammalian kidneyUBERON:000008289.83gold quality
metanephros cortexUBERON:001053388.38gold quality
fallopian tubeUBERON:000388988.11gold quality
kidneyUBERON:000211387.11gold quality
metanephrosUBERON:000008184.78gold quality
tibialis anteriorUBERON:000138584.14gold quality
cortex of kidneyUBERON:000122583.70gold quality
islet of LangerhansUBERON:000000681.88gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099181.54gold quality
ileal mucosaUBERON:000033180.86gold quality
urinary bladderUBERON:000125580.29gold quality
granulocyteCL:000009479.86gold quality
right lobe of thyroid glandUBERON:000111978.08gold quality
bloodUBERON:000017877.89gold quality
renal medullaUBERON:000036277.05gold quality
germinal epithelium of ovaryUBERON:000130476.94gold quality
leukocyteCL:000073876.79gold quality
right lungUBERON:000216776.74gold quality
monocyteCL:000057676.69gold quality
left lobe of thyroid glandUBERON:000112076.34gold quality
thyroid glandUBERON:000204676.19gold quality
cardiac muscle of right atriumUBERON:000337975.24gold quality
left ventricle myocardiumUBERON:000656674.84gold quality
upper lobe of left lungUBERON:000895274.00gold quality

Single-cell (SCXA)

Detected in 5 experiment(s), a significant marker in 5.

ExperimentMarker?Max mean expression
E-GEOD-81547yes1866.04
E-GEOD-114530yes405.37
E-MTAB-5061yes18.47
E-MTAB-9388yes7.40
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

34 targeting ERP27, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-216A-3P99.9571.192505
HSA-MIR-128-3P99.9571.172484
HSA-MIR-218-5P99.9372.222103
HSA-MIR-132199.8465.301811
HSA-MIR-473999.8465.251832
HSA-MIR-4756-5P99.8464.981809
HSA-MIR-130B-5P99.8368.501888
HSA-MIR-312899.5067.851258
HSA-MIR-65799.4866.02848
HSA-MIR-4797-5P99.3968.011354
HSA-MIR-593-3P99.2267.281327
HSA-MIR-427999.1966.702437
HSA-MIR-607199.1667.771780
HSA-MIR-143-5P98.9868.87946
HSA-MIR-6760-5P98.8766.731515
HSA-MIR-5197-3P98.7167.051905
HSA-MIR-3928-5P98.5067.48980
HSA-MIR-6806-3P98.5067.31980
HSA-MIR-211-3P98.1466.771052
HSA-MIR-392197.8167.451431
HSA-MIR-127-5P97.7867.64869
HSA-MIR-89097.4768.67982
HSA-MIR-3187-3P97.3865.80904
HSA-MIR-4653-5P97.2267.721429
HSA-MIR-320197.1665.421044
HSA-MIR-570296.6868.21958
HSA-MIR-1212896.6766.981471
HSA-MIR-6866-5P96.6468.06624

Literature-anchored findings (GeneRIF, showing 3)

  • ERp27 is bound by ERp57 both in vitro and in vivo by a similar mechanism by which ERp57 binds calreticulin (PMID:16940051)
  • ERp27 is able to distinguish between folded and unfolded substrates, only interacting with the latter and presenting them to for catalysis. (PMID:23192347)
  • High-resolution NMR studies of structure and dynamics of human ERp27 indicate extensive interdomain flexibility (PMID:23234573)

Cross-species orthologs

10 orthologs

OrganismSymbolGene ID
mus_musculusErp27ENSMUSG00000030219
rattus_norvegicusErp27ENSRNOG00000005787
drosophila_melanogasterERp60FBGN0033663
drosophila_melanogasterTmx3FBGN0036579
drosophila_melanogasterPdiFBGN0286818
caenorhabditis_elegansWBGENE00003962
caenorhabditis_elegansWBGENE00003963
caenorhabditis_eleganspdi-3WBGENE00003964
caenorhabditis_elegansM04D5.1WBGENE00014807
caenorhabditis_elegansZK973.11WBGENE00022836

Paralogs (13): ERP44 (ENSG00000023318), PDIA5 (ENSG00000065485), TMX4 (ENSG00000125827), TMX1 (ENSG00000139921), PDIA6 (ENSG00000143870), TXNDC11 (ENSG00000153066), PDIA4 (ENSG00000155660), TMX3 (ENSG00000166479), PDIA3 (ENSG00000167004), PDILT (ENSG00000169340), PDIA2 (ENSG00000185615), P4HB (ENSG00000185624), TXNDC5 (ENSG00000239264)

Protein

Protein identifiers

Endoplasmic reticulum resident protein 27Q96DN0 (reviewed: Q96DN0)

Alternative names: Inactive protein disulfide-isomerase 27

All UniProt accessions (2): Q96DN0, F5GYS6

UniProt curated annotations — full annotation on UniProt →

Function. Specifically binds unfolded proteins and may recruit protein disulfide isomerase PDIA3 to unfolded substrates. Binds protein substrates via a hydrophobic pocket in the C-terminal domain. May play a role in the unfolded stress response.

Subunit / interactions. Interacts with PDIA3.

Subcellular location. Endoplasmic reticulum lumen.

Induction. Induced by ER stress.

Similarity. Belongs to the protein disulfide isomerase family.

RefSeq proteins (2): NP_001287713, NP_689534* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR036249Thioredoxin-like_sfHomologous_superfamily

Pfam: PF13848

Enzyme classification (BRENDA):

  • EC 5.3.4.1 — protein disulfide-isomerase (BRENDA: 81 organisms, 481 substrates, 347 inhibitors, 35 Km, 6 kcat entries)

Substrate kinetics (BRENDA)

15 substrates with measured Km, best-characterized 15. Km ranges are aggregated across organisms/conditions.

SubstrateKm (mM)Measurements
CYSTEINE1–33
MYCOTHIOL-COUPLED HYDROXYETHYL DISULFIDE0.46–33.693
RIBONUCLEASE0.002–0.013
RNASE A0.007–0.053
2-MERCAPTOETHANOL0.2–0.82
DITHIOTHREITOL0.003–0.00542
GSH5–172
RNASE0.028–0.0632
SCRAMBLED RIBONUCLEASE0.0011–0.00332
DENATURED-REDUCED LYSOZYME0.02531
INSULIN2.0261
INSULIN-(SS)0.0051
SCRAMBLED REOXIDIZED LYSOZYME0.01161
SCRAMBLED RNASE0.021
SRNASE0

UniProt features (36 total): helix 11, strand 9, mutagenesis site 6, turn 3, signal peptide 1, chain 1, domain 1, region of interest 1, short sequence motif 1, glycosylation site 1, sequence variant 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
4F9ZX-RAY DIFFRACTION2.2
2L4CSOLUTION NMR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96DN0-F186.760.79

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 100

Mutagenesis-validated functional residues (6):

PositionPhenotype
231greatly reduces pdia3 binding in vivo and in vitro.
232greatly reduces pdia3 binding in vivo and in vitro.
233greatly reduces pdia3 binding in vivo and in vitro.
168decreases somatostatin-14 binding.
196decreases somatostatin-14 binding.
196conserved pdia3 binding in vivo and in vitro.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 97 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, GCANCTGNY_MYOD_Q6, GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, CAGCTG_AP4_Q5, GOBP_PROTEIN_MATURATION, GOBP_PROTEIN_FOLDING, RICKMAN_HEAD_AND_NECK_CANCER_A, GOBP_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN, GOCC_ENDOPLASMIC_RETICULUM_LUMEN, MARSON_BOUND_BY_FOXP3_STIMULATED, chr12p12, GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY, GOMF_ISOMERASE_ACTIVITY, FEVR_CTNNB1_TARGETS_UP, GOMF_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY

GO Biological Process (3): protein folding (GO:0006457), response to unfolded protein (GO:0006986), response to endoplasmic reticulum stress (GO:0034976)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): endoplasmic reticulum (GO:0005783), endoplasmic reticulum lumen (GO:0005788)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular process1
protein maturation1
response to topologically incorrect protein1
cellular response to stress1
binding1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1
endoplasmic reticulum1
intracellular organelle lumen1

Protein interactions and networks

STRING

1251 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ERP27PDIA3P30101945
ERP27CALRP27797703
ERP27TXNP10599689
ERP27ERP29P30040605
ERP27ERP44Q9BS26569
ERP27TMX3Q96JJ7568
ERP27PDIA5Q14554558
ERP27TXNDC12O95881516
ERP27TXNDC5Q8NBS9513
ERP27AGR3Q8TD06496
ERP27CLSTN3Q9BQT9491
ERP27TMX1Q9H3N1486
ERP27TMX4Q9H1E5476
ERP27CANXP27824468
ERP27DNAJC10Q8IXB1464
ERP27AGR2O95994464

IntAct

48 interactions, top by confidence:

ABTypeScore
TAP1TAPBPpsi-mi:“MI:0914”(association)0.800
ERP27SGTApsi-mi:“MI:0915”(physical association)0.780
SGTAERP27psi-mi:“MI:0915”(physical association)0.780
EEF1DERP27psi-mi:“MI:0915”(physical association)0.740
ERP27UBQLN1psi-mi:“MI:0915”(physical association)0.670
UBQLN1ERP27psi-mi:“MI:0915”(physical association)0.670
ERP27UBQLN1psi-mi:“MI:0915”(physical association)0.560
UBQLN1ERP27psi-mi:“MI:0915”(physical association)0.560
C12orf60ERP27psi-mi:“MI:0915”(physical association)0.560
GOLGA8FERP27psi-mi:“MI:0915”(physical association)0.560
ERP27UBQLN2psi-mi:“MI:0915”(physical association)0.560
UBL4AERP27psi-mi:“MI:0915”(physical association)0.560
ERP27MED20psi-mi:“MI:0915”(physical association)0.560
BLOC1S2ERP27psi-mi:“MI:0915”(physical association)0.560
HTTERP27psi-mi:“MI:0915”(physical association)0.560
DDX11DNAJA2psi-mi:“MI:0914”(association)0.530

BioGRID (30): ERP27 (Two-hybrid), ERP27 (Two-hybrid), ERP27 (Two-hybrid), ERP27 (Two-hybrid), ERP27 (Two-hybrid), ERP27 (Two-hybrid), GOLGA8F (Two-hybrid), C12orf60 (Two-hybrid), UBQLN2 (Two-hybrid), BLOC1S2 (Two-hybrid), VARS (Affinity Capture-MS), EEF1A2 (Affinity Capture-MS), CARS (Affinity Capture-MS), EEF1D (Affinity Capture-MS), EEF1B2 (Affinity Capture-MS)

ESM2 similar proteins: A0A8M1N5Y4, A3KPF5, D7SFH9, O13811, O44342, P12865, P32474, P38658, P52588, Q0E0I1, Q0JD42, Q10057, Q17688, Q32L47, Q43116, Q498R3, Q4N4N8, Q53LQ0, Q54EN4, Q5FVM7, Q5R5L3, Q5RCM7, Q5WA72, Q5XI02, Q5ZKZ4, Q66GQ3, Q67IX6, Q69ST6, Q6AUC6, Q6NRT6, Q6P5E4, Q7XRB5, Q8IXB1, Q8N807, Q8VX13, Q8VZQ0, Q8W4J3, Q94F09, Q95LM0, Q96DN0

Diamond homologs: D3Z6P0, D4B2L8, G4NFB7, O13811, O22263, O48773, P00275, P04785, P05307, P07237, P08003, P09102, P09103, P0AA25, P0AA26, P0AA27, P0AA28, P0AA29, P0AA30, P11598, P13667, P17967, P21195, P27773, P29828, P30101, P34329, P38657, P38658, P38659, P38660, P38661, P52588, P52589, P54399, P55059, P75512, P80284, P97493, P97615

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

49 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance45
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1375 predictions. Top by Δscore:

VariantEffectΔscore
12:14915672:C:CTacceptor_gain1.0000
12:14917322:T:Cacceptor_gain1.0000
12:14917325:CAG:Cacceptor_gain1.0000
12:14917326:A:Tacceptor_gain1.0000
12:14917327:G:GCacceptor_gain1.0000
12:14917332:G:Cacceptor_gain1.0000
12:14917332:G:GCacceptor_gain1.0000
12:14921045:CTAC:Cacceptor_gain1.0000
12:14933145:A:ACdonor_gain1.0000
12:14933146:C:CCdonor_gain1.0000
12:14934852:TTAC:Tdonor_loss1.0000
12:14934853:TACCA:Tdonor_loss1.0000
12:14934854:A:ACdonor_gain1.0000
12:14934855:C:CTdonor_gain1.0000
12:14934855:CCAGG:Cdonor_gain1.0000
12:14934989:AAATC:Aacceptor_gain1.0000
12:14934992:TC:Tacceptor_gain1.0000
12:14934993:CC:Cacceptor_gain1.0000
12:14934994:C:CCacceptor_gain1.0000
12:14934994:C:Tacceptor_gain1.0000
12:14937948:TAAC:Tdonor_loss1.0000
12:14937949:AACCT:Adonor_loss1.0000
12:14938049:CCAT:Cacceptor_gain1.0000
12:14938050:CAT:Cacceptor_gain1.0000
12:14938050:CATC:Cacceptor_gain1.0000
12:14938051:AT:Aacceptor_gain1.0000
12:14938052:TCTAG:Tacceptor_loss1.0000
12:14938053:C:CCacceptor_gain1.0000
12:14938053:CT:Cacceptor_loss1.0000
12:14914779:CTTT:Cacceptor_gain0.9900

AlphaMissense

1817 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:14915678:A:CF195L0.976
12:14915678:A:TF195L0.976
12:14915680:A:GF195L0.976
12:14934919:G:CS90R0.974
12:14934919:G:TS90R0.974
12:14934921:T:GS90R0.974
12:14917198:C:GA186P0.964
12:14934860:C:GR110P0.957
12:14915507:G:CF252L0.956
12:14915507:G:TF252L0.956
12:14915509:A:GF252L0.956
12:14917197:G:TA186D0.953
12:14917263:A:GL164P0.952
12:14917210:A:CY182D0.946
12:14915596:C:GA223P0.944
12:14920977:G:CF135L0.943
12:14920977:G:TF135L0.943
12:14920979:A:GF135L0.943
12:14937962:C:TG62D0.938
12:14915519:A:CF248L0.936
12:14915519:A:TF248L0.936
12:14915521:A:GF248L0.936
12:14915590:A:CY225D0.935
12:14937958:G:CF63L0.929
12:14937958:G:TF63L0.929
12:14937960:A:GF63L0.929
12:14937968:A:TV60D0.928
12:14934861:G:TR110S0.927
12:14915627:G:CF212L0.925
12:14915627:G:TF212L0.925

dbSNP variants (sampled 300 via entrez): RS1000374341 (12:14926023 T>C), RS1000414203 (12:14931818 G>A,C), RS1000434611 (12:14936917 G>A,T), RS1000508491 (12:14940469 A>G), RS1000686643 (12:14935644 C>T), RS1000717024 (12:14935910 T>C,G), RS1000801089 (12:14921112 T>C), RS1000807224 (12:14936718 C>A,G,T), RS1000808452 (12:14920821 T>C), RS1001062613 (12:14925991 C>A), RS1001195227 (12:14919830 T>C,G), RS1001219164 (12:14913786 T>C,G), RS1001232833 (12:14935967 C>T), RS1001248895 (12:14914016 C>G), RS1001301205 (12:14930717 T>C)

Disease associations

OMIM: gene MIM:610642 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

5 associations (top):

StudyTraitp-value
GCST005235_5Hand grip strength2.000000e-12
GCST009596_4Osteoarthritis of the hand2.000000e-15
GCST90007527_4Low hand grip strength (60 years and older) (EWGSOP)4.000000e-09
GCST90010716_1Hand osteoarthritis severity (hand Klsum)3.000000e-12
GCST90010717_1Finger osteoarthritis severity (hand Klsum)5.000000e-14

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0006941grip strength measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

60 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidincreases expression, decreases expression, affects cotreatment6
Benzo(a)pyreneaffects methylation, decreases expression, increases methylation5
trichostatin Aaffects cotreatment, increases expression3
sodium arsenitedecreases expression3
Cyclosporinedecreases expression3
bisphenol Aaffects expression2
mercuric bromideaffects cotreatment, increases expression2
perfluoro-n-nonanoic aciddecreases expression2
entinostatdecreases expression, affects cotreatment2
Vorinostataffects cotreatment, increases expression2
Panobinostataffects cotreatment, increases expression2
Estradiolaffects cotreatment, increases expression, decreases expression2
Ethinyl Estradiolaffects expression, decreases expression2
Phenylmercuric Acetateaffects cotreatment, increases expression2
Tetrachlorodibenzodioxindecreases expression2
Tobacco Smoke Pollutiondecreases expression2
Tretinoinincreases expression2
Aflatoxin B1affects expression, increases methylation2
Cadmium Chloridedecreases expression, increases abundance2
p-Chloromercuribenzoic Acidaffects cotreatment, increases expression2
dicrotophosdecreases expression1
methyleugenoldecreases expression1
triphenyl phosphateaffects expression1
propionaldehydedecreases expression1
terbufosincreases methylation1
3,4-dichloroanilinedecreases expression1
butyraldehydedecreases expression1
perfluorooctanoic aciddecreases expression1
1-hydroxypyrenedecreases expression1
pentanaldecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): osteoarthritis, hand